Capricor Therapeutics
CAPR
CAPR
34 hedge funds and large institutions have $18.9M invested in Capricor Therapeutics in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
6% more funds holding
Funds holding: 32 → 34 (+2)
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
Holders
34
Holding in Top 10
–
Calls
$574K
Puts
$338K
Top Buyers
| 1 | +$15.7M | |
| 2 | +$453K | |
| 3 | +$346K | |
| 4 |
Millennium Management
New York
|
+$252K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$150K |
Top Sellers
| 1 | -$294K | |
| 2 | -$167K | |
| 3 | -$139K | |
| 4 |
Jane Street
New York
|
-$63.4K |
| 5 |
Morgan Stanley
New York
|
-$58.7K |